Synonyms: ATI-501 | ATI50001 | ATI501 | example 103 [WO2007070872A1]
Compound class:
Synthetic organic
Comment: ATI-50001 (ATI-501) is an orally bioactive kinase inhibitor, with selectivity for Janus kinases (JAK) 1/3. It was claimed in Rigel Pharmaceuticals' 2007 patent WO2007070872A1 [1], but it was later developed by Aclaris Therapeutics.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
3-[[2-(3,4,5-trimethoxyanilino)-7H-purin-6-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide |
Synonyms |
ATI-501 | ATI50001 | ATI501 | example 103 [WO2007070872A1] |
Database Links | |
CAS Registry No. | 942137-77-1 (source: PubChem) |
GtoPdb PubChem SID | 479821108 |
PubChem CID | 23585272 |
Search Google for chemical match using the InChIKey | NDUGGMXIZKDJRM-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | NDUGGMXIZKDJRM |
UniChem Compound Search for chemical match using the InChIKey | NDUGGMXIZKDJRM-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NDUGGMXIZKDJRM-UHFFFAOYSA-N |